glp 1 vs glp 2 weight loss Part of a 3-Part Series; GLP-1 Medications for What Happens After GLP-1 Weight

Semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have experienced especially strong uptake following their FDA approvals

Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa, resulting in improved efficacy and reduced systemic exposure for the treatment of ulcerative colitis

Metabolic dysfunction -associated steatotic liver disease MASLD, also known as fatty liver/NAFLD-non alcoholic liver disease, is a condition commonly associated with being overweight

I 2 = 27%) compared with metformin, but not for HbA1c (MD: -0.05, 95% CI: -0.19, 0.09

Sources: Wharton S, Lingvay I, Bogdanski P, et al

Tirzepatide Tirzepatide is a dual agonist, meaning it acts as both a GLP-1 and GIP receptor agonist